(lp0
S"Inovio Pharmaceuticals'  CEO J. Joseph Kim on Q4 2016 Results - Earnings ... Seeking Alpha - 9 hours ago Greetings, and welcome to the Inovio Pharmaceuticals Fourth Quarter and Year End Financial Results Conference Call. At this time all participants are in a listen-only mode an interactive question-and-answer session will follow the formal presentation.Earnings Reaction History: Inovio Pharmaceuticals, Inc, 63.6% Follow-Through ... - NasdaqInovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results - Yahoo Finance"
p1
aS'Biogen, Inovio Pharmaceuticals, Rubicon Project Times of India - 29 minutes ago HIGHLIGHTS * Biogen Inc : Morgan Stanley cuts to equal-weight from overweight * Inovio Pharmaceuticals Inc : Piper Jaffray cuts to neutral from overweight * Oracle Corp : Deutsche Bank raises target price to $44 from $40; rating hold * Rubicon Project ...'
p2
aS'How Risky Is Inovio Pharmaceuticals, Inc.? Motley Fool - Jan 5, 2017 Last year was extremely eventful for Inovio Pharmaceuticals, Inc.  as it made headlines with a Zika virus candidate and suffered a regulatory setback.'
p3
aS'Analyst Downgrades  Inovio Pharmaceuticals  Stock Gets Downgraded ... Market Exclusive - 1 hour ago Inovio Pharmaceuticals, Inc.  is a bio-pharmaceutical company, which is involved in developing deoxyribonucleic acid  immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases.'
p4
aS"3 Reasons Inovio Pharmaceuticals Inc. Stock Could Rise Motley Fool - Aug 19, 2016 There's good news and bad news in 2016 for Inovio Pharmaceuticals  shareholders. The good news is that Inovio's stock is up around 30% year to date."
p5
aS"The Potential and Peril with Inovio Pharmaceuticals, Inc. Motley Fool - Nov 12, 2016 Cory also correctly noted that Inovio finished mid-stage testing of its experimental cervical dysplasia vaccine VGX-3100 over two years ago and still hadn't begun enrolling for the planned late-stage study when the U.S.HC Wainwright Cuts Price Target For Inovio Pharmaceuticals Inc , But ... - Smarter Analyst"
p6
aS"Inovio Pharmaceuticals, Inc. in 3 Charts Motley Fool - Sep 13, 2016 Shareholders of Inovio Pharmaceuticals  didn't have much to smile about in 2014 and 2015. This year, however, is a much different story.Inovio's Zika Vaccine Bags Tech Award  - Investopedia"
p7
aS"The Biggest Threat to Inovio Pharmaceuticals, Inc. Stock Motley Fool - Apr 27, 2016 You're probably a happy camper if you bought shares of Inovio Pharmaceuticals  at the beginning of 2016. The biotech's stock is up over 55% year to date -- and that's after starting off the year with a big drop."
p8
aS"Inovio Pharmaceuticals, Inc.'s Biggest Win in 2016 Motley Fool - Dec 9, 2016 If 2016 had stopped in June, it would have been a fantastic year for Inovio Pharmaceuticals . The biotech's stock shot up around 70% by mid-way through the year."
p9
aS"Why Inovio Pharmaceuticals Inc. Is Soaring Today Motley Fool - May 9, 2016 What: Shares of Inovio Pharmaceuticals , a clinical-stage biopharmaceutical company primarily focused on developing vaccines, jumped by as much as 11% in early morning trading before pulling back a bit in response to the company's&nbsp;...Inovio Pharmaceuticals Inc  "
p10
a.